The George Institute for Global Health is thrilled to congratulate doctoral researcher Dr Lauren Heath on receiving a ...

In this Q&A, Mineralys CEO Jon Congleton discusses how targeting aldosterone could reshape hypertension treatment. Aldosterone synthase inhibitors (ASIs) are drawing a lot of attention. What first ...

Lorundrostat, a novel therapy which blocks the production of aldosterone from the adrenal glands, demonstrated clinically meaningful and sustained reductions in blood pressure in 1,083 patients with ...

A new pill called baxdrostat is showing strong results in lowering dangerously high blood pressure in people who don’t ...

Scientists have now developed a new drug called baxdrostat, which offers hope by lowering blood pressure in these tough cases ...